from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3477/PE31

LFCtreatmentdescriptionclass of inhibitor

0.818

Amikacinug/mL Amikacintranslation

0.800

Cap5-10ug/mL Capreomycintranslation

1.023

Rox10-50 ug/mL Roxithromycintranslation

-0.214

SM2-5 ug/mL Streptomycintranslation

0.619

Tet5-10 ug/mL Tetracyclinetranslation

-1.112

Rif0.2-5ug/mL Rifampicintranscription

-0.524

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.958

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.037

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.235

CPZ10-50 ug/mL Chlorpromazinerespiration

0.526

Clofazimine10-13 ug/mL Clofaziminerespiration

0.679

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.837

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.116

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.789

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.579

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.736

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.252

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.829

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.089

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.330

KCN5-20 ug/mL Potassium cyaniderespiration

-0.579

NaN30.2-2 mM Sodium aziderespiration

0.597

Nigericin50 uM Nigericinrespiration

-1.371

TRC10-150 ug/mL Triclosanrespiration

-0.750

TRZ10-25 ug/mL Thioridazinerespiration

-1.746

Valinomycin0.5-10 uM Valinomycinrespiration

0.903

ZnSO42 mM ZnSO4respiration

-1.248

menadione6-10 ug/mL Menadionerespiration

0.823

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.719

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.618

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.753

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.404

NRP_1Non-replicating persistence stage 1dosRassociated

0.858

Amp0.2mg/mL AmpicillincellWall

0.715

Cephalexin20-100 ug/mL CephalexincellWall

0.306

Cerulenin0.32-5 ug/mL CerulenincellWall

0.432

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.317

EMB10-20 ug/mL EthambutolcellWall

0.593

Eta12-40 ug/mL EthionamidecellWall

0.918

INH0.2-0.4 ug/mL IsoniazidcellWall

-1.787

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.350

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.236

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.374

BZA0.12 mg/mL BenzamidearomaticAmides

0.530

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.617

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.643

H2O24 mM hydrogen peroxideDNAdamaging

0.220

Levo10 ug/mL LevofloxacinDNAdamaging

0.098

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.164

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.331

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.602

UVUV-irradiationDNAdamaging

-0.843

ARP41-4 ug/mL Antitubercular compound ARP4?

0.479

Antimycin12.5-50 ug/mL Antimycin A?

0.611

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.322

PA_110-50 ug/mL Antitubercular compound PA-1?

0.397

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.292

PA8240.2-2 ug/mL PA-824?

-1.236

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.294

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.714

Verapamil50 uM Verapamil?

0.636

mercaptoethanol2 mM 2-Mercaptoethanol?

0.666

methoxatin10-20 ug/mL Methoxatin?